# Rondo Therapeutics

**Canonical:** https://apis.io/providers/rondo-therapeutics/  
**Website:** https://www.rondotx.com  
**APIs profiled:** 0

Rondo Therapeutics is a clinical-stage biotechnology company based in Hayward, California, developing immune-cell engaging bispecific antibodies designed to treat solid tumors by unleashing the immune system while maximizing efficacy and minimizing side effects. Founded in 2019 by Shelley Force Aldred and Nathan Trinklein, its pipeline includes RNDO-564 (Phase 1 for bladder cancer) plus programs targeting ovarian, endometrial, and renal cancers, backed by a Series A led by Canaan and Red Tree Venture Capital and a collaboration with Eli Lilly. Rondo publishes a corporate and pipeline website but exposes no public developer program, API, or machine-readable API surface; it was surfaced as a portfolio company of canaan-partners and added to the API Evangelist network for enrichment.

## Kin Score — 9.2 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.2).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Therapeutics, Oncology, Antibodies, Immunotherapy, Pharmaceuticals

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/rondo-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.